Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
Feature articles “Basic and Clinical Research on Brain-Targeted Drug Delivery Systems” Editor:Mariko Takeda
Application of Molecular Imaging Technology for Innovative Drug Development Targeting to Brain
Yousuke KanayamaTomotaka ShingakiHirotaka OnoeYasuyoshi Watanabe
Author information
JOURNAL FREE ACCESS

2013 Volume 28 Issue 4 Pages 328-334

Details
Abstract
In vivo molecular imaging is a key technology for an innovative drug development. In particular, positron emission tomography(PET) has been applied to many studies in diagnosis, PK/PD, and DDS, since PET has superior sensitivity, quantitativity, and molecular multiplicity among other molecular imaging modalities. The brain is known to be kept its homeostasis by the blood-brain barrier that strictly limits the penetration of both endogenous and exogenous substances from the systemic circulation. In the development of drug targeting to the brain, molecular imaging technique is highly useful, because it enables the analysis of drug biodistribution in the brain, non-invasively in vivo. Here we introduced PET studies for the analysis of drug transporters in the blood-brain barrier, the visualization and evaluation of pharmacokinetics and pharmacodynamics of drugs in the brain as examples in effective use of molecular imaging technique for the drug development.
Content from these authors
© 2013 Japan Society of Drug Delivery System
Previous article
feedback
Top